Drug intelligence / Profile preview

NovoGluten

Development stage
Preclinical
Lead developer
Novoviah Pharmaceuticals
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

NovoGluten is a standardized clinical gluten product developed by Novoviah Pharmaceuticals for use in celiac disease clinical trials and gluten challenge studies. It is designed to provide consistent and credible gluten material to elicit and measure immune responses in patients with celiac disease. The product undergoes extensive testing for protein content, water, R5-ELISA, and microbiology, and is evaluated in stability studies under various storage conditions. It serves as a standardized challenge or diagnostic material rather than a therapeutic agent, helping researchers inform study design, statistical powering, and analysis for celiac disease research. The active ingredient consists of gluten protein derived from wheat, barley, and/or rye.

Brand names
NovoGluten
Other names
clinical gluten productgluten challenge material

Beyond the preview

Go deeper on NovoGluten.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovoGluten.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call